Biocon settles US patent dispute with Roche’s Genentech, eyes 2027 Perjeta biosimilar launch by India News Online Team October 15, 2026 0 Roche's Genentech has settled a US lawsuit against Indian biopharmaceutical company Biocon over its proposed biosimilar of Genentech's blockbuster breast-cancer drug Perjeta, Biocon said Wednesday.* Biocon said in a ...